Cargando…
Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study
Glioblastoma (GBM) is the most common and aggressive type of tumour arising from the central nervous system. GBM remains an incurable disease despite advancement in therapies, with overall survival of approximately 15 months. Recent literature has highlighted that GBM releases tumoural content which...
Autores principales: | Müller Bark, Juliana, Kulasinghe, Arutha, Hartel, Gunter, Leo, Paul, Warkiani, Majid Ebrahimi, Jeffree, Rosalind L., Chua, Benjamin, Day, Bryan W., Punyadeera, Chamindie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210776/ https://www.ncbi.nlm.nih.gov/pubmed/34150645 http://dx.doi.org/10.3389/fonc.2021.681130 |
Ejemplares similares
-
The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
por: Kulasinghe, Arutha, et al.
Publicado: (2018) -
Circulating biomarkers in patients with glioblastoma
por: Müller Bark, Juliana, et al.
Publicado: (2019) -
Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
por: Kulasinghe, Arutha, et al.
Publicado: (2017) -
PD-L1 expressing circulating tumour cells in head and neck cancers
por: Kulasinghe, Arutha, et al.
Publicado: (2017) -
Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips
por: Kulasinghe, Arutha, et al.
Publicado: (2019)